Negative regulation of transforming growth factor-β by the proteoglycan decorin
✍ Scribed by Yamaguchi, Yu; Mann, David M.; Ruoslahti, Erkki
- Book ID
- 109764268
- Publisher
- Nature Publishing Group
- Year
- 1990
- Tongue
- English
- Weight
- 483 KB
- Volume
- 346
- Category
- Article
- ISSN
- 0028-0836
- DOI
- 10.1038/346281a0
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Transforming growth factor-beta (TGF-beta) has been implicated in the in vivo resistance of the EMT-6/CTX and EMT-6/ CDDP murine mammary tumors. Both of these tumors have a higher number of intratumoral vessels than the EMT-6/ parent tumor. Animals bearing the resistant tumors have higher plasma lev
## Regulation of transforming growth factor-p production by interleukin-= The induction of peripheral tolerance following oral antigen administration in several autoimmune disease and conventional animal models correlates with the production of transforming growth factor-fJ (TGF-p) and T helper ty
JORMA KESKI-OJA Two types of transforming growth factors (TGF) have been purified and well characterized, TGFa and TGFP. TGFa is a 5.6 kD single chain molecule that shows sequence homology to epidermal growth factor (EGF), binds to the EGF receptor, and has biological effects very similar to those o
Transforming growth factor- (TGF-) represents an evolutionarily conserved family of secreted factors that mobilize a complex signaling network to control cell fate by regulating proliferation, differentiation, motility, adhesion, and apoptosis. TGF- promotes the assembly of a cell surface recepto